Drug Report History #228166
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v3-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated (Changed) | Updated to: 2024-07-10 | Was: 2024-05-17 |
| Drug Identification Number | 02240749 | 02240749 |
| Brand name | SUPREFACT DEPOT 3 MONTHS | SUPREFACT DEPOT 3 MONTHS |
| Common or Proper name | buserelin acetate implant | buserelin acetate implant |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Ingredients | BUSERELIN | BUSERELIN |
| Strength(s) | 9.45MG | 9.45MG |
| Dosage form(s) | IMPLANT | IMPLANT |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 applicator | 1 applicator |
| Additional packaging sizes | ||
| ATC code | L02AE | L02AE |
| ATC description | HORMONES AND RELATED AGENTS | HORMONES AND RELATED AGENTS |
| Reason for discontinuation | Manufacturing issues | Manufacturing issues |
| Anticipated discontinuation date | ||
| Actual discontinuation date (Changed) | Updated to: | Was: 2024-05-16 |
| Remaining supply date (Changed) | Updated to: | Was: 2024-05-16 |
| Discontinuation status (Changed) | Updated to: Reversed | Was: Discontinued |
| Discontinuation decision reversal (Changed) | Updated to: yes | Was: no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments (Changed) | Updated to: Product will be in shortage with an unknown end date | Was: |